(Total Views: 113)
Posted On: 07/21/2023 11:30:46 AM
Post# of 27112
$MRK News Article - Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ?1) https://marketwirenews.com/news-releases/merc...44134.html
(0)
(0)
My Twitter: WhyteStocks
